HOUSE-BILL 7877: H.R.7877 - Shane DiGiovanna Act
AI-Powered Summary
HOUSE-BILL 7877 aims to enhance health care access for individuals suffering from epidermolysis bullosa by mandating Medicaid coverage for specific treatments related to this condition. The legislation addresses major themes of health care equity and federal-state relations, particularly concerning the rights of individuals to receive necessary medical care. Key provisions include the establishment of a nationwide demonstration program to test mandatory coverage for wound care treatments, which is expected to improve health outcomes for affected individuals. Additionally, the bill imposes reporting requirements on the Secretary of Health and Human Services to evaluate the program's effectiveness and report findings to Congress, ensuring accountability. The potential impacts of this legislation include improved access to essential medical supplies and treatments for individuals with epidermolysis bullosa, while also raising constitutional questions about federal authority over state Medicaid programs and the implications for states' rights under the Tenth Amendment.
Demographic Impact Analysis
Summary
Overall Constitutional Implications
The bill has significant implications for individuals with epidermolysis bullosa, as it mandates coverage for necessary treatments under Medicaid, thereby enhancing access to health care for a vulnerable population. This aligns with broader public health goals and the government's role in ensuring health care access.
Key Individual Rights
- Right to Health Care
- Equal Protection under the Law
Constitutional Provisions
- 14th Amendment - Equal Protection Clause
Potential Constitutional Challenges Or Support
Support
The bill could be seen as a positive step toward fulfilling the government's role in providing health care to vulnerable populations, potentially reducing health disparities.
Concerns
- Equal Protection: The bill may create disparities in health care access for individuals with other conditions not covered under this program.
- State Autonomy: The federal requirement for states to include specific treatments may be challenged as an overreach of federal authority.
- Funding: Questions may arise regarding the adequacy of funding for Medicaid programs if mandated coverage leads to increased expenditures.
Summary
HOUSE-BILL 7877 aims to significantly improve access to medical care for individuals with epidermolysis bullosa by mandating coverage under Medicaid. While it raises important questions about equal protection and state autonomy, the bill primarily supports the right to health care for a vulnerable population, aligning with constitutional principles aimed at reducing health disparities.
Constitutional Analysis
This bill appears to align with constitutional principles. The proposed legislation operates within the established framework of constitutional authority and does not appear to conflict with fundamental rights or the separation of powers.
Analysis generated using AI-powered review of constitutional principles and legal precedents.
Take Action
Text 50409
💡 How to use:
These links will start a conversation with ResistBot. When prompted, mention H.R. 7877 to reference this bill.
Contact Your Representatives
Write to YOUR elected officials about this bill
Rate This Bill
Sign in to save a private rating for this bill and track your civic engagement over time.
Sign In FreeTimeline
March 9, 2026
Bill Introduced
Current
Introduced
June 12, 2026
Last Updated
Ask the Constitutional AI About This Bill
Sign in free to chat with our constitutional analysis AI about this bill — get plain-English explanations, constitutional concerns, and demographic impact estimates personalized to you.
Sign In Free to Chat